Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Mefenamic acid poisoning |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Accidental mefenamic acid poisoning (disorder) |
Causative agent (attribute) |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
|
Intentional mefenamic acid poisoning |
Causative agent (attribute) |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
|
intoxication par l'acide méfénamique d'intention indéterminée |
Causative agent (attribute) |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid adverse reaction |
Causative agent (attribute) |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
|
Allergy to mefenamic acid |
Causative agent (attribute) |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
|
Mefenamic acid overdose |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Accidental mefenamic acid overdose |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Intentional mefenamic acid overdose |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
surdose d'acide méfénamique d'intention indéterminée |
Causative agent (attribute) |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid [cns analgesic] [see j2b..] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
|
Mefenamic acid [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
|
Mefenamic acid 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
|
Mefenamic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
|
Mefenamic acid 50mg/5mL pediatric suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
|
Product containing mefenamic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Adverse reaction to mefenamic acid |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Accidental mefenamic acid poisoning (disorder) |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Intentional mefenamic acid poisoning |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Allergy to mefenamic acid |
Causative agent (attribute) |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid 250 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid 250 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid 10 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid 10 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only mefenamic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing drotaverine and mefenamic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Drotaverine and mefenamic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Drotaverine- and mefenamic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Drotaverine and mefenamic acid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing mefenamic acid and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Mefenamic acid and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing mefenamic acid and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only mefenamic acid and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mefenamic acid 10 milligram/1 milliliter and paracetamol 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely mefenamic acid 10 milligram/1 milliliter and paracetamol 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
2 |
Dicycloverine and mefenamic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing only dicycloverine and mefenamic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dicycloverine hydrochloride 10 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dicycloverine hydrochloride 10 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing dicycloverine and mefenamic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing dicycloverine and mefenamic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mefenamic acid 500 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mefenamic acid 500 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mefenamic acid (substance) |
Inferred relationship |
Some |
1 |